Paper14969769
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G and 13 others. Hum Immunol, 2004. Cited by 139 papers, by iCite.
Cite this record
ConductScience Library. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Papers, record 14969769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14969769
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
- PubMed
Topics34
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD28 Antigens | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Immune Tolerance | Major topic |
| T-Lymphocytes | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Antibodies, Monoclonal | |
| Antibody-Dependent Cell Cytotoxicity | |
| Antigen Presentation | |
| CD3 Complex | |
| CD4-Positive T-Lymphocytes | |
| CD8 Antigens | |
| Cell Communication | |
| Cell Differentiation | |
| Cell Proliferation | |
| Coculture Techniques | |
| Culture Media, Conditioned | |
| Dendritic Cells | |
| Flow Cytometry | |
| Granulocyte-Macrophage Colony-Stimulating Factor | |
| Histocompatibility Antigens Class I | |
| Humans | |
| Interleukin-10 | |
| Interleukin-2 | |
| Leukocyte Common Antigens | |
| Lymphocyte Activation | |
| Monocytes | |
| Receptors, Antigen, T-Cell, alpha-beta | |
| Receptors, CCR7 | |
| Receptors, Chemokine | |
| Receptors, Interleukin | |
| Receptors, Interleukin-10 | |
| T-Lymphocytes, Cytotoxic | |
| Tuberculin | |
| Tumor Necrosis Factor Receptor Superfamily, Member 7 |
Source PubMed
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41373714 | TCR-Based Antigen-Specific Therapy for Type 1 Diabetes Mellitus: From Editing Autoreactive Clones to Tolerance Induction. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373714 | PubMed |
| 41349560 | CD8+ Regulatory T Cells. | Annu Rev Immunol | 2026 | https://conductscience.org/library/papers/41349560 | PubMed |
| 40312697 | Comparison of circulating immune signatures across different consensus molecular subtypes (CMS) and between left- and right-sided lesions in stage II colorectal cancer using single-cell mass cytometry. | J Transl Med | 2025 | https://conductscience.org/library/papers/40312697 | PubMed |
| 39592626 | Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study. | Nat Commun | 2024 | https://conductscience.org/library/papers/39592626 | PubMed |
| 39085655 | Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/39085655 | PubMed |
| 36189271 | OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications. | Front Immunol | 2022 | https://conductscience.org/library/papers/36189271 | PubMed |
| 36105795 | Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36105795 | PubMed |
| 35954318 | Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35954318 | PubMed |
| 35258440 | Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy. | Hum Vaccin Immunother | 2022 | https://conductscience.org/library/papers/35258440 | PubMed |
| 35055071 | Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35055071 | PubMed |
| 34899714 | Newly Found Peacekeeper: Potential of CD8+ Tregs for Graft-Versus-Host Disease. | Front Immunol | 2021 | https://conductscience.org/library/papers/34899714 | PubMed |
| 34831195 | Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease. | Cells | 2021 | https://conductscience.org/library/papers/34831195 | PubMed |
| 34335631 | CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs. | Front Immunol | 2021 | https://conductscience.org/library/papers/34335631 | PubMed |
| 34066538 | Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34066538 | PubMed |
| 33072584 | Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis. | Front Oncol | 2020 | https://conductscience.org/library/papers/33072584 | PubMed |
| 32774487 | Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32774487 | PubMed |
| 31199313 | Stimulation of Nucleotide Oligomerization Domain and Toll-Like Receptors 2 to Enhance the Effect of Bacillus Calmette Guerin Immunization for Prevention of Mycobacterium Tuberculosis Infection: Protocol for a Series of Preclinical Randomized Controlled Trials. | JMIR Res Protoc | 2019 | https://conductscience.org/library/papers/31199313 | PubMed |
| 31067796 | Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31067796 | PubMed |
| 30728151 | Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/30728151 | PubMed |
| 30459765 | Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV. | Front Immunol | 2018 | https://conductscience.org/library/papers/30459765 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCR7 | 1236 | PubTator's text mining | https://conductscience.org/library/genes/1236 | NCBI Gene |
| CD27 | 939 | PubTator's text mining | https://conductscience.org/library/genes/939 | NCBI Gene |
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CSF2 | 1437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL10RA | 3587 | PubTator's text mining | https://conductscience.org/library/genes/3587 | NCBI Gene |
| PTPRC | 5788 | PubTator's text mining | https://conductscience.org/library/genes/5788 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14969769
GET https://conductscience.org/api/papers/v1/14969769/cited_by?page=2